case_images: PMC8429022_01
case_images: Results of retrospective 6-day continuous glucose monitoring (CGM) system (iPro 2 system, Medtronic MiniMed, Northridge, CA, USA) in the second year (November 2017) following diagnosis revealed normal glucose levels.
case_images: CRIE2021-3511281.001.jpg
case_images: PMC8429022_01_CRIE2021-3511281.001.jpg
case_images: fig1
case_images: Medtronic MiniMed, Northridge, CA, USA) in the second year following diagnosis confirmed normoglycemia as shown in Figure 1. MMST was firstly evaluated at the second year after diagnosis to assess the reserved beta-cell function.
case_images: Clinical course and sequential laboratory data in this patient.
case_images: CRIE2021-3511281.002.jpg
case_images: PMC8429022_01_CRIE2021-3511281.002.jpg
case_images: fig2
case_images: A1C was maintained between 5.0 and 6.2% without any antidiabetic medication for more than 5 years as shown in Figure 2.